Hepatocellular carcinoma and Lung disorder

Summary:

Lung disorder is found among people with Hepatocellular carcinoma, especially for people who are male, 60+ old.

The study analyzes which people have Lung disorder with Hepatocellular carcinoma. It is created by eHealthMe based on reports of 65 people who have Hepatocellular carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatocellular carcinoma?

Hepatocellular carcinoma (liver cancer) is found to be associated with 306 drugs and 731 conditions by eHealthMe. Check the latest studies of Hepatocellular carcinoma.

What is Lung disorder?

Lung disorder (lung disease) is found to be associated with 1,802 drugs and 1,787 conditions by eHealthMe. Check the latest studies of Lung disorder.

On Aug, 02, 2026

65 people who have Hepatocellular Carcinoma and Lung Disorder are studied.

Would you have Lung disorder when you have Hepatocellular carcinoma?

Gender of people who have Hepatocellular Carcinoma and experienced Lung Disorder *:

female: 21.67 %
male: 78.33 %

Age of people who have Hepatocellular Carcinoma and experienced Lung Disorder *:

Common co-existing conditions for these people *:

Diabetes: 2 people, 3.08%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 3.08%
Insomnia (sleeplessness): 2 people, 3.08%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 3.08%
Pain: 2 people, 3.08%
Renal Cell Carcinoma (a kidney cancer): 1 person, 1.54%
Abdominal Pain Upper: 1 person, 1.54%
Bacterial Infection: 1 person, 1.54%
Colon Cancer: 1 person, 1.54%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 1.54%

Common drugs taken by these people *:

Common symptoms for these people *:

Weakness: 13 people, 20.00%
Fatigue (feeling of tiredness): 11 people, 16.92%
General Physical Health Deterioration (weak health status): 11 people, 16.92%
Diarrhea: 10 people, 15.38%
Fever: 9 people, 13.85%
Nausea And Vomiting: 7 people, 10.77%
Hepatic Function Abnormal: 6 people, 9.23%
Abdominal Pain: 6 people, 9.23%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 9.23%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 6 people, 9.23%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lung disorder?

- Check whether Lung disorder is associated with a drug or a condition

Related publications that referenced our studies

Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .

Related studies:

Treatments, associated drugs and conditions:

Hepatocellular carcinoma (32,153 reports)
Lung disorder (66,567 reports)

All the drugs that are associated with Lung disorder:

Lung disorder (1,802 drugs)

All the conditions that are associated with Lung disorder:

Lung disorder (1,787 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lung disorder and Hepatocellular carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.